Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-2 | 48.0 | 62 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | IL-2 | 49.0 | 67 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | IL-2 | 52.0 | 49 | ||||
RA2159 | 2 | IL-2 | 50.0 | 61 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | IL-2 | 47.0 | 38 | ||||
N2645 | 2 | IL-2 | 45.0 | 48 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | IL-2 | 42.0 | 48 | ||||
RA2708 | 2 | IL-2 | 43.5 | 42 | |||||||
0 | IL-2 | 47.0 | 36 | ||||||||
0 | IL-2 | 53.0 | 43 | ||||||||
0 | IL-2 | 45.0 | 45 | ||||||||
0 | IL-2 | 60.0 | 73 | ||||||||
0 | IL-2 | 61.0 | 57 | ||||||||
0 | IL-2 | 58.0 | 38 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-2 | 57.5 | 58 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | IL-2 | 53.0 | 69 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-2 | 49.0 | 67 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | IL-2 | 48.0 | 73 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-2 | 64.5 | 70 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | IL-2 | 56.0 | 57 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-2 | 53.0 | 66 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL-2 | 53.0 | 54 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | IL-2 | 57.0 | 50 | ||||
RA1869 | 3 | IL-2 | 43.0 | 49 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | IL-2 | 52.0 | 59 |